Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
CPERT · 1 trial · 1 indication
CPERT safety will be assessed by evaluation of vital signs (pre-injection and post-imaging), blood haematology (pre-injection and post-imaging), SMA-12 clinical biochemistry profile (pre-injection and post-imaging) and collection of adverse events.
| Arm | Type | Description |
|---|---|---|
| Arm Number 1 CPERT | EXPERIMENTAL | 1 CPERT scan, blood and vital sign collection |
| Arm Number 2 GPERT | ACTIVE_COMPARATOR | 1 GPERT Scan |
| Name | Type | Description |
|---|---|---|
| CPERT | DRUG | Single 340 MBq CPERT scan in first 10 subjects |
| GPERT | DRUG | Single 340 MBq GPERT scan in up to 20 case-matched controls |
Inclusion Criteria: * If female of child-bearing potential and outside of the window of 10 days since the first day of the last menstrual period, a negative pregnancy test is required. * Have confirmed well differentiated thyroid cancer, post-thyroidectomy and pre-RAI * Biochemical parameters as me...
CPERT is an investigational small molecule being studied for use in thyroid neoplasms, which are tumors of the thyroid gland. It is currently in Phase 1 clinical development as a diagnostic or imaging agent for this condition.
CPERT is being developed by Avalon GloboCare Corp., a biopharmaceutical company. The company's stock is traded under the ticker symbol ALBT.
CPERT is in Phase 1 clinical development. It is an investigational drug and has not been approved by regulatory authorities. One Phase 1 trial has been completed, and the drug is not currently in any active clinical trials.
CPERT has one completed clinical trial, identified as NCT01437254. This Phase 1 study compared the safety and imaging patterns of cyclotron-produced technetium versus generator-produced technetium in patients with thyroid cancer. The trial enrolled 30 participants in Canada.
CPERT is a small molecule that contains technetium, a radioactive element used in medical imaging. It is designed to be used as an imaging agent to visualize thyroid tissue or tumors, helping to assess thyroid neoplasms.